USE OF BETA-ADRENOCEPTOR AGONISTS IN COMBINATION WITH NMDA ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

摘要

The invention relates to the use of beta -adrenoceptor agonists for restoring and/or maintaining the function of partially or fully damaged/degenerated cells of the central nervous system and/or other nerve cells. Using beta 2-adrenoceptor agonists enables astrocytes to be activated and endogenous neuroprotection processes to be stimulated, whereby the damage or destruction of nerve cells can be reduced and even prevented in some cases.